|
Harrison TM, Ward TJ, Murphy A, et al. Optimizing quantification of MK6240 tau PET in unimpaired older adults. Neuroimage. 2023;265:119761. doi:10.1016/j.neuroimage.2022.119761
|
|
15th Conference Clinical Trials Alzheimer’s Disease, November 29–December 2, 2022, San Francisco, CA, USA: Posters (Clinical Trial Alzheimer’s Disease). J Prev Alzheimers Dis. 2022;9(Suppl 1):51-248. doi:10.14283/jpad.2022.97
|
|
Hill M. Grassroots Approaches To Community-Based Representative Recruitment In Multidomain Trials. Innov Aging. 2021;5(Suppl 1):67-68. Published 2021 Dec 17. doi:10.1093/geroni/igab046.260
|
|
Baker L. The Science Behind Multidomain Interventions to Slow Cognitive Decline. Innov Aging. 2021;5(Suppl 1):67. Published 2021 Dec 17. doi:10.1093/geroni/igab046.258
|
|
Kivipelto M, Mangialasche F, Snyder HM, et al. World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia. Alzheimers Dement. 2020;16(7):1078-1094. doi:10.1002/alz.12123
|
|
Espeland MA, Baker LD, Carrillo MC, et al. INCREASING ADHERENCE IN A CENTER-BASED TRIAL OF LIFESTYLE INTERVENTION IN OLDER INDIVIDUALS: U.S. POINTER TRIAL. Innov Aging. 2018;2(Suppl 1):809. Published 2018 Nov 11. doi:10.1093/geroni/igy023.3011
|
|
Röhr S, Arai H, Mangialasche F, et al. Impact of the COVID-19 pandemic on statistical design and analysis plans for multidomain intervention clinical trials: Experience from World-Wide FINGERS. Alzheimers Dement (N Y). 2021;7(1):e12143. Published 2021 Mar 11. doi:10.1002/trc2.12143
|
